Vivo Capital is a global healthcare investment firm with a multi-strategy platform covering venture capital, private equity, and public equity strategies. The firm catalyzes innovation and growth in healthcare markets, leveraging its "Ecosystem Strategy" to support healthcare access expansion and facilitate international partnerships. With over $5.8 billion in active AUM and a track record of 97+ IPOs and M&As, Vivo Capital operates from its headquarters in Palo Alto and has offices in Asia.
Recent Transactions involving Vivo Capital
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital | Bain Capital |
Pearl Biotechnology |
Avistone Pharmaceuticals |
Bain CapitalVivo CapitalPrimavera Capital |
Biotechnology |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →